Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Duarte

Showing results (611-620 of 680) with videos related to

Pageof 68
Sort By:
Bone Marrow Transplantation|April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert groupMarion Larue, Florent Malard, Ahmed S Alaskar, et al.
Bone Marrow Transplantation|August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party studyTapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
Communications Biology|February 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogrammingWazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini, et al.
Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Frontiers in Immunology|May 1, 2020
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working PartyOlaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Vox Sanguinis|February 3, 2023
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasmaIrene Romera Martínez, José Luis Bueno Cabrera, José María Domingo-Morera, et al.
Bone Marrow Transplantation|March 24, 2015
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)M Mohty, F Malard, M Abecassis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 1, 2025
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G CommitteeGandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Bone Marrow Transplantation|October 1, 2025
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G CommitteeGandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Cancer Research Communications|October 13, 2025
Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic SarcomaMiguel Esperança-Martins, Hugo Vasques, Manuel Sokolov Ravasqueira, et al.
Pageof 68

Showing results (611-620 of 680) with videos related to

Sort By:
Pageof 68
Bone Marrow Transplantation|April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert groupMarion Larue, Florent Malard, Ahmed S Alaskar, et al.
Bone Marrow Transplantation|August 12, 2023
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party studyTapani Ruutu, Christophe Peczynski, Mohamed Houhou, et al.
Communications Biology|February 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogrammingWazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini, et al.
Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Frontiers in Immunology|May 1, 2020
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working PartyOlaf Penack, Christophe Peczynski, Steffie van der Werf, et al.
Vox Sanguinis|February 3, 2023
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasmaIrene Romera Martínez, José Luis Bueno Cabrera, José María Domingo-Morera, et al.
Bone Marrow Transplantation|March 24, 2015
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)M Mohty, F Malard, M Abecassis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 1, 2025
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G CommitteeGandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Bone Marrow Transplantation|October 1, 2025
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G CommitteeGandhi Damaj, Adèle de Masson, Peter Dreger, et al.
Cancer Research Communications|October 13, 2025
Succinate Dehydrogenase B (SDHB) Overexpression with Enzymatic Dysfunction Defines a Distinct Subtype of Undifferentiated Pleomorphic SarcomaMiguel Esperança-Martins, Hugo Vasques, Manuel Sokolov Ravasqueira, et al.
Pageof 68